25 Posts Not to Miss from ESMO Congress 2026: Day 4
DeLLphi-304 Trial: Tarlatamab Versus Chemotherapy in SCLC
OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition Part 2
Gilberto Lopes: Key Insights from ESMO 2026
Amol Akhade: An Indian Phase III Trial With the Potential to Change Practice in Oral Cavity Cancer
Julie Gralow։ ESMO - ASCO Joint Session Explored the Evolving Definition of the Modern Oncologist
Toufic Kachaamy: Neoadjuvant Immunotherapy is Changing Colorectal Cancer Care
OptiTROP-Breast01 Final Analysis: Sacituzumab Tirumotecan Sustains Overall Survival Benefit in Previously Treated Metastatic Triple-Negative Breast Cancer
The ImmunoRad Asia 2027 Conference, held in collaboration with the World Immunotherapy Council Asia-Pacific (WIC APAC), will take place on March 1–2, 2027, at Academia, Singapore General Hospital Campus, in […]
